Company
Headquarters: Oakland, CA, United States
CEO: Mr. Edward M. Schmults
$86.2 Million
USD as of Sept. 1, 2022
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Harborside Inc. engages in the cultivation, manufacture, distribution, wholesale, and retail of cannabis and cannabis products for the adult-use and medical markets in California. It owns and operates three retail dispensaries under the Harborside brand located in Oakland, San Jose, and San Leandro, California; and a dispensary under the Terpene Station brand name located in Eugene, Oregon, as well as manages and operates a dispensary under the Harborside brand under a management services agreement located in Desert Hot Springs, California. The company also operates approximately 47 acres of cultivation/production facility located in Salinas, California. It sells its products under the Harborside, Harborside Farms, Harborside Farms Reserve, and KEY brand names. Harborside Inc. has a strategic research agreement with Utah State University. The company was founded in 2006 and is headquartered in Oakland, California.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Harborside, Inc. has the following listings and related stock indices.
Stock: OTC: HBORF wb_incandescent
Stock: CSE: HBOR wb_incandescent